retatrutide clinical trial retatrutide drug Retatrutide: FDA approval time, results & weight loss Retatrutide Phase 3: 60% Achieved

Expected 12-month results include 15 to 22% body weight loss (50 to 75 pounds for a 300-pound person), 5 to 8 inch waist circumference reduction, major improvement in mobility and physical function, and often dramatic improvement or resolution of obesity-related health conditions including sleep apnea, fatty liver disease, and joint pain

It also plays a key role in detoxifying the liver, supporting immunity, and maintaining an even skin tone

That said, we're big believers in being safe

While the 2mg dose did show improved results for blood sugar control and weight loss in many participants, the researchers also noted an increase in side effects

Maternal high-fat diet during lactation reprograms the dopaminergic circuitry in mice